Skip to main content
Clinical Trials/NCT04091828
NCT04091828
Unknown
Not Applicable

Assessment of Cognitive Functions in Bipolar Disorder Patients

Assiut University0 sites72 target enrollmentOctober 2019

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Bipolar Disorder
Sponsor
Assiut University
Enrollment
72
Primary Endpoint
Assessment of severity of mania in bbipolar patients
Last Updated
6 years ago

Overview

Brief Summary

Assessment of cognitive function in manic bipolar patient

Detailed Description

Assessment of severity of mania and depression in bipolar patients then evaluate their cognitive function.

Registry
clinicaltrials.gov
Start Date
October 2019
End Date
November 2022
Last Updated
6 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Marwa Salama Ahmed Omar

Assessment of cognitive function in bipolar patients

Assiut University

Eligibility Criteria

Inclusion Criteria

  • Aged 18-55 years
  • Of both sex
  • Diagnosed as bipolar by DSM-5(patient)

Exclusion Criteria

  • Current medical and psychiatric comorbidities which may affect cognitive status.
  • Substance abuse or dependence (except nicotine and caffeine)in last month.
  • Somatic treatment with drugs known to affect cognitive status (cortisol, antihistamines, etc.)

Outcomes

Primary Outcomes

Assessment of severity of mania in bbipolar patients

Time Frame: 2019-2022

EVALUATE manic patients by Young Mania Rating Scale (YMRS)

Assessment of severity of depression in bipoiar patients

Time Frame: 2019-2022

Evaluate depressed patients by Hamilton Rating Scale for depression(HRS).

Assessment of cognitive function in bipoiar patients

Time Frame: 2019-2022

Evaluate cognition in included patients by Montreal Cognitive Assessment(MOCA) and P300.

Secondary Outcomes

  • Correlation between cognitive state in bipolar patient and(onset age,illness duration and number of episodes).(2019-2021)

Similar Trials